Sign in

    Matthew J. Harrigan

    Research Analyst at Wunderlich Securities, Inc.

    Matthew J. Harrigan's questions to Regencell Bioscience Holdings (RGC) leadership

    Matthew J. Harrigan's questions to Regencell Bioscience Holdings (RGC) leadership • Q2 2016

    Question

    Matthew J. Harrigan from Wunderlich Securities, Inc. inquired if declining mall traffic was creating a performance gap between mall-based and standalone theatres. He also asked for commentary on the upcoming film slate, particularly any potential 'sleeper' hits.

    Answer

    Chairman & CEO Amy E. Miles stated that the company is not seeing any performance divergence between its mall and non-mall locations, as the theatre itself remains the primary draw. She did note a future trend toward building in lifestyle centers. Executive VP, CFO & Treasurer David H. Ownby expressed general optimism for the upcoming film slate but refrained from providing specific box office guidance or highlighting individual films.

    Ask Fintool Equity Research AI